Occurrence of thymic pathology in two families. Is familial screening justified?

https://doi.org/10.4081/monaldi.2018.913

Authors

  • Sotirios D. Moraitis Athens Naval and Veterans Hospital, Department of Thoracic Surgery, Greece.
  • Apostolos C. Agrafiotis | apostolos.agrafiotis@gmail.com Tenon University Hospital, Department of Thoracic Surgery, France.
  • Amalia Kapranou Athens Naval and Veterans Hospital, Department of Pathology, Greece.
  • Marina Constantinou Athens Naval and Veterans Hospital, Department of Pathology, Greece.
  • Konstantinos Kanakakis Athens Naval and Veterans Hospital, Department of Thoracic Surgery, Greece.
  • Panagiotis Hountis Athens Naval and Veterans Hospital, Department of Thoracic Surgery, Greece.

Abstract

The familial occurrence of thymic pathology, even though rare, is widely reported in the literature and mainly concerns cases of familial autoimmune myasthenia gravis. Other less frequent cases of familial occurrence of thymoma, thymic carcinoid and thymic hyperplasia have been described. It seems that the familial occurrence is poorly recorded and thus its prevalence is underestimated. We report two families whose members presented different forms of thymic pathology and discuss the necessity of screening programs in family members of patients presenting a thymic lesion.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2018-09-04
Info
Issue
Section
Pneumology - Case Reports
Keywords:
Familial, thymoma, thymic carcinoma, thymic hyperplasia.
Statistics
  • Abstract views: 550

  • PDF: 379
How to Cite
Moraitis, Sotirios D., Apostolos C. Agrafiotis, Amalia Kapranou, Marina Constantinou, Konstantinos Kanakakis, and Panagiotis Hountis. 2018. “Occurrence of Thymic Pathology in Two Families. Is Familial Screening Justified?”. Monaldi Archives for Chest Disease 88 (3). https://doi.org/10.4081/monaldi.2018.913.

Most read articles by the same author(s)